Maturitas
Volume 67, Issue 3 , Pages 233-238, November 2010

Women's voices in the menopause: Results from an international survey on vaginal atrophy

  • Rossella E. Nappi

      Affiliations

    • Research Center for Reproductive Medicine, Department of Morphological, Eidological and Clinical Sciences, University of Pavia, Italy
    • Gynecological Endocrinology and Menopause Unit, Department of Internal Medicine and Endocrinology, IRCCS “S Maugeri Foundation”, Pavia, Italy
    • Corresponding Author InformationCorresponding author at: Gynecological Endocrinology and Menopause Unit, Department of Internal Medicine and Endocrinology, IRCCS “S Maugeri Foundation”, University of Pavia, Via Ferrata 8, 27100 Pavia, Italy. Tel.: +39 0382 592201; fax: +39 0382 536176.
  • ,
  • Marta Kokot-Kierepa

      Affiliations

    • Novo Nordisk FemCare AG, Andreasstrasse 15, CH-8050 Zurich, Oerlikon, Switzerland

Received 22 July 2010; received in revised form 8 August 2010; accepted 8 August 2010. published online 01 September 2010.

Abstract 

Objectives

To consider issues relating to vaginal atrophy via an international survey.

Methods

Using a structured questionnaire, interviews were performed on 4246 women aged 55–65 years living in Sweden, Finland, the United Kingdom, the United States and Canada.

Results

Overall, 98% of survey respondents were postmenopausal. Thirty-nine percent of the postmenopausal women had experienced vaginal atrophy, with the prevalence varying between countries, from 34% in Canada to 43% in Finland and the United States. Attitudes towards symptoms also varied between countries. Symptoms were described as moderate or severe by less than half of women from Finland and Sweden, compared with nearly two-thirds of women from the United States. However, vaginal atrophy was deemed to impact on quality of life by a higher proportion of women in Finland and Sweden (≥60%) than in the United Kingdom, the United States and Canada (≤50%). Overall, 77% of respondents believed women were uncomfortable discussing vaginal atrophy and 42% did not know that local treatment was available. The proportions of women unaware of the availability of local treatment were higher in the United States, the United Kingdom and Canada (51%, 50% and 48%, respectively), and very low in Finland (10%). Whilst 63% of women who had experienced vaginal atrophy had never been prescribed treatment for the condition, 67% of those who had been treated reported positive effects.

Conclusion

The survey results illustrate differing needs of menopausal women in different countries. Country-specific approaches may be required to improve the uptake of treatment for vaginal atrophy.

Keywords: Attitude, Menopause, Survey, Vaginal atrophy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-5122(10)00314-2

doi:10.1016/j.maturitas.2010.08.001

Maturitas
Volume 67, Issue 3 , Pages 233-238, November 2010